사양
- 인증 기준: ChP, USP, BP, EP, JP, IP, Ph. Int 약전 기준
- IUPAC Name: 20-[[(1S)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propano
- EC Number:
- Molecular Weight: 4813
- Chemical Formula: C225H348N48O68
- CAS Number: 2023788-19-2
- 순도: 99%(맞춤 가능)
- 용도: 2형 당뇨병용 GIP/GLP-1 이중 수용체 작용제(마운자로)
- Appearance: White Powder
- Usage: Tirzepatide injection is used to treat type 2 diabetes.
- Eptifibatide: 188627-80-7
- Terlipressin Acetate: 14636-12-5
- Astosiban Acetate: 90779-69-4
- Liraglutide: 204656-20-2
- Teriparatide: 52232-67-4
- Bivalirudin: 128270-60-0
- Carbetocin: 37025-55-1
- Thymosin Beta 4: 77591-33-4
- Calcitonin: 60731-46-6
- Semaglutide: 910463-68-2
- Abaloparatide: 247062-33-5
평가 & 댓글 남기기